SCHEMBL30183020

SCHEMBL30183020

N#Cc1cncc2ccncc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
NCOA3 Q9Y6Q9 1/20 0.54
CCNT1 O60563 1/20 0.49
CDK9 P50750 1/20 0.49
HASPIN Q8TF76 1/20 0.49
DYRK1A Q13627 8/20 0.43
CLK1 P49759 6/20 0.43
CLK2 P49760 6/20 0.43
CLK4 Q9HAZ1 6/20 0.43
DYRK1B Q9Y463 6/20 0.43
CDK5 Q00535 5/20 0.43
CDK5R1 Q15078 5/20 0.43
CLK3 P49761 4/20 0.43
HIPK2 Q9H2X6 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ELANE P08246 1/20 0.38
TNF P01375 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31354899 0.98 HTT (0.58) HTTNCOA3CCNT1CDK9HASPIN
SCHEMBL2011043 0.80 HTT (0.42) HTTNCOA3CCNT1CDK9HASPIN
SCHEMBL7015267 0.78 HTT (0.73) HTTNCOA3CCNT1CDK9HASPIN
SCHEMBL1551634 0.78 HTT (0.61) HTTNCOA3DYRK1ACLK1CLK2
SCHEMBL31588148 0.78 HTT (0.61) HTTNCOA3DYRK1ACLK1CLK2
SCHEMBL27600515 0.76 HTT (0.59) HTTNCOA3DYRK1ACDK5CDK5R1
Hydrochloric Acid SCHEMBL11816471 0.76 HTT (0.59) HTTNCOA3DYRK1ACDK5CDK5R1
SCHEMBL1202005 0.74 HTT (1.00) HTTNCOA3CCNT1CDK9HASPIN
SCHEMBL29546988 0.73 HTT (0.50) HTTNCOA3CCNT1CDK9HASPIN
SCHEMBL20043 0.73 HTT (0.50) HTTNCOA3CCNT1CDK9HASPIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4412710-A1 SMALL MOLECULES FOR TREATEMENT OF CANCER Vrise Therapeutics, Inc. (US) 2024-08-14 EP claimed
WO-2023057985-A1 SMALL MOLECULES FOR TREATEMENT OF CANCER VRISE THERAPEUTICS, INC. (US) 2023-04-13 WO claimed
WO-2023285583-A1 5,6,7,8-TETRAHYDRO-2,6- AND 2,7-NAPHTHYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES RESPONSIVE TO CITRATE TRANSPORTER MODULATION ETERNYGEN UK LTD. (GB) 2023-01-19 WO disclosed